Home › NDC Lookup › RxCUI directory › RxCUI 1551622

84 HR estradiol 0.00104 MG/HR Transdermal System [Minivelle] — RxCUI 1551622

RxNorm drug concept · Semantic branded drug
RxCUI 1551622 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1551622
Official name84 HR estradiol 0.00104 MG/HR Transdermal System [Minivelle]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMinivelle 0.00104 MG/HR 84 HR Transdermal Patch; Minivelle 0.025 MG/Day Twice Weekly Transdermal System; 84 HR Minivelle 0.00104 MG/HR Transdermal System; Minivelle 0.025 MG per 24 HR Twice Weekly Transdermal Patch
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)17,500 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Estradiol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The estradiol gel 0.1% label (Elestrin) lists it for moderate to severe hot flashes and night sweats from menopause. Estrace is a vaginal cream, and its uses aren’t described in th...
  • Apply one full packet once a day to the upper thigh, alternating sides. Let it dry before dressing. Don’t wash the spot for 1 hour, keep it off your face, breasts and vaginal area,...
  • Breast tenderness, spotting or irregular bleeding, and cold-like symptoms were the most common. Headache and nausea have also been reported. These are worth mentioning to your pres...
  • Get emergency help for signs of a stroke, blood clot, or heart attack, or for hives and swelling. Sudden vision loss or double vision means you should stop and be checked right awa...
📖 Read our full Estradiol Topical guide →

🕸️ Concept Web — How 84 HR estradiol 0.00104 MG/HR Transdermal System... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 84 HR estradiol 0.00104 MG/HR Transdermal System [Minivelle] RxCUI 1551622

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Estradiol 4083
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Minivelle 1356974
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Estradiol Transdermal System 1805869
    • Estradiol Topical Product 1165762
    • Estradiol Transdermal Product 1294793
    • Estradiol Transdermal System [Minivelle] 1805946
    • Minivelle Topical Product 1356977
    • Minivelle Transdermal Product 1356978
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Estradiol 0.00104 MG/HR [Minivelle] SBDC · 1551621
  • Estradiol Transdermal System [Minivelle] SBDF · 1805946
  • Minivelle Topical Product SBDG · 1356977
  • Minivelle Transdermal Product SBDG · 1356978
  • Minivelle BN · 1356974

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 1551622 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68968-6610-08 8 POUCH in 1 PACKET (68968-6610-8) / 1 d in 1 POUCH Minivelle Noven Therapeutics, LLC 2012-12-20
68968-6625-08 8 POUCH in 1 PACKET (68968-6625-8) / 1 d in 1 POUCH Minivelle Noven Therapeutics, LLC 2012-12-20
68968-6637-08 8 POUCH in 1 PACKET (68968-6637-8) / 1 d in 1 POUCH Minivelle Noven Therapeutics, LLC 2012-12-20
68968-6650-08 8 POUCH in 1 PACKET (68968-6650-8) / 1 d in 1 POUCH Minivelle Noven Therapeutics, LLC 2012-12-20
68968-6675-08 8 POUCH in 1 PACKET (68968-6675-8) / 1 d in 1 POUCH Minivelle Noven Therapeutics, LLC 2012-12-20
Observed labelers: Noven Therapeutics, LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.